Literature DB >> 1917926

Evaluation of deoxygenated oligosaccharide acceptor analogs as specific inhibitors of glycosyltransferases.

O Hindsgaul1, K J Kaur, G Srivastava, M Blaszczyk-Thurin, S C Crawley, L D Heerze, M M Palcic.   

Abstract

The glycosyltransferases controlling the biosynthesis of cell-surface complex carbohydrates transfer glycosyl residues from sugar nucleotides to specific hydroxyl groups of acceptor oligosaccharides. These enzymes represent prime targets for the design of glycosylation inhibitors with the potential to specifically alter the structures of cell-surface glycoconjugates. With the aim of producing such inhibitors, synthetic oligosaccharide substrates were prepared for eight different glycosyltransferases. The enzymes investigated were: A, alpha(1----2, porcine submaxillary gland); B, alpha(1----3/4, Lewis); C, alpha(1----4, mung bean); D, alpha(1----3, Lex)-fucosyltransferases; E, beta(1----4)-galactosyltransferase; F, beta(1----6)-N-acetylglucosaminyltransferase V; G, beta(1----6)-mucin-N-acetylglucosaminyltransferase ("core-2" transferase); and H, alpha(2----3)-sialyltransferase from rat liver. These enzymes all transfer sugar residues from their respective sugar nucleotides (GDP-Fuc, UDP-Gal, UDP-GlcNAc, and CMP-sialic acid) with inversion of configuration at their anomeric centers. The Km values for their synthetic oligosaccharide acceptors were in the range of 0.036-1.3 mM. For each of these eight enzymes, acceptor analogs were next prepared where the hydroxyl group undergoing glycosylation was chemically removed and replaced by hydrogen. The resulting deoxygenated acceptor analogs can no longer be substrates for the corresponding glycosyltransferases and, if still bound by the enzymes, should act as competitive inhibitors. In only four of the eight cases examined (enzymes A, C, F, and G) did the deoxygenated acceptor analogs inhibit their target enzymes, and their Ki values (all competitive) remained in the general range of the corresponding acceptor Km values. No inhibition was observed for the remaining four enzymes even at high concentrations of deoxygenated acceptor analog. For these latter enzymes it is suggested that the reactive acceptor hydroxyl groups are involved in a critical hydrogen bond donor interaction with a basic group on the enzyme which removes the developing proton during the glycosyl transfer reaction. Such groups are proposed to represent logical targets for irreversible covalent inactivation of this class of enzyme.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1917926

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  The N-acetyl-binding pocket of N-acetylglucosaminyltransferases also accommodates a sugar analog with a chemical handle at C2.

Authors:  Marta Pasek; Boopathy Ramakrishnan; Elizabeth Boeggeman; Natalia Mercer; Andres E Dulcey; Gary L Griffiths; Pradman K Qasba
Journal:  Glycobiology       Date:  2011-08-25       Impact factor: 4.313

2.  Aglycone structure influences alpha-fucosyltransferase III activity using N-acetyllactosamine glycoside acceptors.

Authors:  Y Miura; S Kim; J R Etchison; Y Ding; O Hindsgaul; H H Freeze
Journal:  Glycoconj J       Date:  1999-11       Impact factor: 2.916

3.  UDP-Gal: GlcNAc-R beta1,4-galactosyltransferase--a target enzyme for drug design. Acceptor specificity and inhibition of the enzyme.

Authors:  Inka Brockhausen; Melinda Benn; Shridhar Bhat; Sandra Marone; John G Riley; Pedro Montoya-Peleaz; Jason Z Vlahakis; Hans Paulsen; John S Schutzbach; Walter A Szarek
Journal:  Glycoconj J       Date:  2006-11       Impact factor: 2.916

4.  Processing O-glycan core 1, Gal beta 1-3GalNAc alpha-R. Specificities of core 2, UDP-GlcNAc: Gal beta 1-3 GalNAc-R(GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase and CMP-sialic acid: Gal beta 1-3GalNAc-R alpha 3-sialyltransferase.

Authors:  W Kuhns; V Rutz; H Paulsen; K L Matta; M A Baker; M Barner; M Granovsky; I Brockhausen
Journal:  Glycoconj J       Date:  1993-10       Impact factor: 2.916

5.  Deoxygenated disaccharide analogs as specific inhibitors of beta1-4-galactosyltransferase 1 and selectin-mediated tumor metastasis.

Authors:  Jillian R Brown; Feng Yang; Anjana Sinha; Boopathy Ramakrishnan; Yitzhak Tor; Pradman K Qasba; Jeffrey D Esko
Journal:  J Biol Chem       Date:  2008-12-23       Impact factor: 5.157

6.  Disaccharide uptake and priming in animal cells: inhibition of sialyl Lewis X by acetylated Gal beta 1-->4GlcNAc beta-O-naphthalenemethanol.

Authors:  A K Sarkar; T A Fritz; W H Taylor; J D Esko
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

7.  Synthetic substrate analogues for UDP-GlcNAc: Man alpha 1-6R beta(1-2)-N-acetylglucosaminyltransferase II. Substrate specificity and inhibitors for the enzyme.

Authors:  F Reck; E Meinjohanns; M Springer; R Wilkens; J A Van Dorst; H Paulsen; G Möller; I Brockhausen; H Schachter
Journal:  Glycoconj J       Date:  1994-06       Impact factor: 2.916

8.  Substrate specificity and inhibition of UDP-GlcNAc:GlcNAc beta 1-2Man alpha 1-6R beta 1,6-N-acetylglucosaminyltransferase V using synthetic substrate analogues.

Authors:  I Brockhausen; F Reck; W Kuhns; S Khan; K L Matta; E Meinjohanns; H Paulsen; R N Shah; M A Baker; H Schachter
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

Review 9.  Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer.

Authors:  Andréia Vasconcelos-Dos-Santos; Isadora A Oliveira; Miguel Clodomiro Lucena; Natalia Rodrigues Mantuano; Stephen A Whelan; Wagner Barbosa Dias; Adriane Regina Todeschini
Journal:  Front Oncol       Date:  2015-06-25       Impact factor: 6.244

Review 10.  Tumor-Associated Glycans as Targets for Immunotherapy: The Wistar Institute Experience/Legacy.

Authors:  Magdalena Thurin
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.